RB1 and cancer: Additionally, when compared to other cancer types, RB1 is subject to CN-LOH at much higher rates in retinoblastoma than in other cancers that also contain mutations in RB1 (p-value < 2.2 × 10−16, OR 44.4) (Figure 2D).